Reading QDEL? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track QDEL free→Reading QDEL? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track QDEL free→QuarterlyIQ Insights · QDEL
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On May 5, 2026, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its first quarter ended March 29, 2026 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on May 5, 2026 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnished…
Results of Operations and Financial Condition. On April 15, 2026, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing its preliminary unaudited revenue for its first quarter of 2026, ended March 29, 2026. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 18, 2026, Michelle A. Hodges, the Chief Legal Officer and Corporate Secretary of QuidelOrtho Corporation (the “Company”), notified the Company of her plans to retire from these roles, effective March 23, 2026 (the “Effective Date”), to be concurrent with the Company’s appointment of a successor Chief Legal Officer and Corporate Secretary.…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 9, 2026, Joseph M. Busky, the Chief Financial Officer and principal financial officer of QuidelOrtho Corporation (the “Company”), notified the Company of his plans to retire effective as of June 30, 2026. Mr. Busky’s decision to retire is for personal reasons and is not the result of any disagreement with the Company or its independent…
Results of Operations and Financial Condition. On February 11, 2026, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its fourth quarter and full year ended December 28, 2025 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on February 11, 2026 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exh…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 30, 2026, Matthew W. Strobeck, a member of the board of directors (the “Board”) of QuidelOrtho Corporation (the “Company”), provided notice to the Board of his decision not to stand for re-election at the Company’s 2026 annual stockholders meeting (the “Annual Meeting”). Dr. Strobeck will continue to serve as a Board member until the Ann…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.